Results 51 to 60 of about 935,058 (290)
Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang +2 more
wiley +1 more source
Obesity raises blood levels of PAI‐1, a protein linked to metabolic dysfunction‐associated steatotic liver disease in people with obesity. In female mice fed a high‐fat diet, partially lowering PAI‐1 led to smaller subcutaneous fat cells and lower liver cholesterol, without changing body weight or insulin sensitivity.
Claudia E. Ramirez Bustamante +10 more
wiley +1 more source
Kurumsal Sosyal Sorumluluğun Satın Alma Niyeti Üzerindeki Etkisi: İstanbul İlinde Bir Araştırma
Bu çalışmanın amacı, kurumsal sosyal sorumluluğun satın alma niyeti üzerindeki etkisinin belirlenmesidir. Bu amaçla tasarlanan araştırmada ekonomik, yasal, etik ve gönüllü sosyal sorumluluk ele alınmış, bu boyutlarla birlikte satın alma niyetini ölçen ...
İlknur Bilgen, Gülsüm Vezir Oğuz
doaj +1 more source
Despite the diverse perspectives on corporate reputation, few studies investigate consumers as a subject of corporate reputation. Thus, this study uncovers the factors that contribute to and comprise the reputation of mobile carriers, compares the ...
Mo Ran Yi
doaj +1 more source
How do genomes gain new functional parts? In eukaryotes, which tend to evolve under weak selection, much of the genome is junk. Palazzo and Qiu borrow the logic of Markov chains to show how non‐functional DNA becomes functional through the appearance of intermediate states, which arise due to epistasis, buffering, and biochemical messiness, allowing ...
Alexander F. Palazzo, Yi Qiu
wiley +1 more source
Prospecting the protein design landscape
This review outlines the current state of various protein design approaches. We discuss the current possibilities enabled by recently released tools, highlight future avenues to pursue in protein design, and underscore the crucial role of key databases and resources for successful protein design workflows.
Jakob R. Riccabona +4 more
wiley +1 more source
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla +9 more
wiley +1 more source
Background: Corporate social performance (CSP) has been widely researched in the past. However, few empirical studies, especially in the African context, have been conducted.
Roselyne Koech, David Coldwell
doaj +1 more source
The Social Responsibility among Higher Education Students
The aim of this research is to emphasize the importance of education for the philanthropic responsibilities of students. The basic term of the explanatory research is corporate social responsibility, adapted for higher education institutions—the ...
Emese Beáta Berei
doaj +1 more source
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source

